SRINAGARIND MEDICAL JOURNAL

Volume 35, No. 01, Month JANUARY, Year 2020, Pages 32 - 37

Result of desferrioxamine administration by retained scalp-vein into subcutaneous in thalassemic patients

Ruenrudee Kaennak, Arunee Jetsrisuparp, Salugchit Srimongkol

Abstract Download PDF

Background and Objective: Thalassemia is a genetic disease. This disease is cured and cared by using supportive treatments such as blood transfusion, and iron chelator. The purpose of this research was to evaluate the results of desferrioxamine administration by retained scalp vein into subcutaneous in thalassemic patients. Methods: This investigation aimed to determine 30 thalassemic patients, age up to 12 years old, who attended the pediatrics clinic at Srinagarind hospital during January - October 2013. The research tool was questionnaires. The data were analyzed by using frequency, percentage, means and standard deviation. Results: The use of desferrioxamine administration by retained scalp vein into subcutaneous in thalassemic patients, have reduced iron levels in 50 percent of the patients. All of the patients accounted for 100 percent able to prepare medication and correctly inject themselves. There satisfactions were in a high level. Therefore, thalassemic patients should be encourage to inject by this method. Conclusion: Desferrioxamine administration by retained scalp-vein into subcutaneous in thalassemic patients can reduce the number of injection. The use of desferrioxamine injection technique was safely carried out and was high satisfaction by patients and caregivers.

Keywords

desferrioxamine, Thalassemia, Scalp-vein, subcutancous

---